• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用3种分子描述符理解活性药物成分构象对无定形分散体形成潜力预测的影响。

Understanding the Influence of API Conformations on Amorphous Dispersion Formation Potential Predictions using the 3 Molecular Descriptor.

作者信息

DeBoyace Kevin, Bookwala Mustafa, Zhou Deliang, Buckner Ira S, Wildfong Peter L D

机构信息

School of Pharmacy and Graduate School of Pharmaceutical Sciences, Duquesne University, 600 Forbes Ave, Pittsburgh, Pennsylvania 15282, United States.

Pfizer Worldwide R&D, Eastern Point Road, Groton, Connecticut 06340, United States.

出版信息

Mol Pharm. 2024 Feb 5;21(2):770-780. doi: 10.1021/acs.molpharmaceut.3c00909. Epub 2024 Jan 5.

DOI:10.1021/acs.molpharmaceut.3c00909
PMID:38181202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10848250/
Abstract

The 3 molecular descriptor (R-GETAWAY third-order autocorrelation index weighted by the atomic mass) has previously been shown to encode molecular attributes that appear to be physically and chemically relevant to grouping diverse active pharmaceutical ingredients (API) according to their potential to form persistent amorphous solid dispersions (ASDs) with polyvinylpyrrolidone-vinyl acetate copolymer (PVPVA). The initial 3 dispersibility model was built by using a single three-dimensional (3D) conformation for each drug molecule. Since molecules in the amorphous state will adopt a distribution of conformations, molecular dynamics simulations were performed to sample conformations that are probable in the amorphous form, which resulted in a distribution of 3 values for each API. Although different conformations displayed 3 values that differed by as much as 0.4, the median of each 3 distribution and the value predicted from the single 3D conformation were very similar for most structures studied. The variability in 3 resulting from the distribution of conformations was incorporated into a logistic regression model for the prediction of ASD formation in PVPVA, which resulted in a refinement of the classification boundary relative to the model that only incorporated a single conformation of each API.

摘要

3分子描述符(由原子质量加权的R-GETAWAY三阶自相关指数)先前已被证明能够编码分子属性,这些属性在物理和化学上似乎与根据不同活性药物成分(API)与聚乙烯吡咯烷酮-醋酸乙烯酯共聚物(PVPVA)形成持久性无定形固体分散体(ASD)的潜力进行分组相关。最初的3分散性模型是通过为每个药物分子使用单一的三维(3D)构象构建的。由于处于无定形状态的分子会采用多种构象分布,因此进行了分子动力学模拟以采样无定形形式中可能的构象,这导致每个API有一个3值分布。尽管不同构象显示的3值差异高达0.4,但对于大多数研究的结构,每个3分布的中位数与从单一3D构象预测的值非常相似。构象分布导致的3的变异性被纳入一个逻辑回归模型,用于预测PVPVA中ASD的形成,这相对于仅纳入每个API单一构象的模型,导致分类边界得到了优化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/11980eae21b2/mp3c00909_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/4011358ef4df/mp3c00909_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/1277b5bfb199/mp3c00909_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/ec36166001f1/mp3c00909_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/58439362902b/mp3c00909_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/83f30a1a6d90/mp3c00909_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/375e36bd4ac8/mp3c00909_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/a6fa8df61ab2/mp3c00909_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/27e83d3a256b/mp3c00909_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/11980eae21b2/mp3c00909_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/4011358ef4df/mp3c00909_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/1277b5bfb199/mp3c00909_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/ec36166001f1/mp3c00909_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/58439362902b/mp3c00909_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/83f30a1a6d90/mp3c00909_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/375e36bd4ac8/mp3c00909_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/a6fa8df61ab2/mp3c00909_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/27e83d3a256b/mp3c00909_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2d/10848250/11980eae21b2/mp3c00909_0009.jpg

相似文献

1
Understanding the Influence of API Conformations on Amorphous Dispersion Formation Potential Predictions using the 3 Molecular Descriptor.利用3种分子描述符理解活性药物成分构象对无定形分散体形成潜力预测的影响。
Mol Pharm. 2024 Feb 5;21(2):770-780. doi: 10.1021/acs.molpharmaceut.3c00909. Epub 2024 Jan 5.
2
Interpreting the Physicochemical Meaning of a Molecular Descriptor Which Is Predictive of Amorphous Solid Dispersion Formation in Polyvinylpyrrolidone Vinyl Acetate.解读对预测聚维酮醋酸乙烯酯无定形固体分散体形成有影响的分子描述符的物理化学意义。
Mol Pharm. 2022 Jan 3;19(1):303-317. doi: 10.1021/acs.molpharmaceut.1c00783. Epub 2021 Dec 21.
3
Modeling and Prediction of Drug Dispersability in Polyvinylpyrrolidone-Vinyl Acetate Copolymer Using a Molecular Descriptor.利用分子描述符对聚乙烯吡咯烷酮-醋酸乙烯酯共聚物中药物分散性的建模与预测
J Pharm Sci. 2018 Jan;107(1):334-343. doi: 10.1016/j.xphs.2017.10.003. Epub 2017 Oct 12.
4
Investigating and Comparing the Applicability of the R3m Molecular Descriptor and Solubility Parameter Estimation Approaches in Predicting Dispersion Formation Potential of APIs in a Random Co-Polymer Polyvinylpyrrolidone Vinyl Acetate and its Homopolymer.研究并比较R3m分子描述符和溶解度参数估算方法在预测活性药物成分在无规共聚物聚乙烯吡咯烷酮-醋酸乙烯酯及其均聚物中形成分散体潜力方面的适用性。
J Pharm Sci. 2023 Jan;112(1):318-327. doi: 10.1016/j.xphs.2022.11.004. Epub 2022 Nov 14.
5
Informatics calibration of a molecular descriptors database to predict solid dispersion potential of small molecule organic solids.信息学校准分子描述符数据库,以预测小分子有机固体的固体分散体潜力。
Int J Pharm. 2011 Oct 14;418(2):217-26. doi: 10.1016/j.ijpharm.2011.06.003. Epub 2011 Jul 3.
6
Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.药物活性成分在聚合物基质中的微尺度溶解度评估和预测模型。
Eur J Pharm Biopharm. 2019 Aug;141:111-120. doi: 10.1016/j.ejpb.2019.05.012. Epub 2019 May 14.
7
Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.从无定形固体分散体中释放药物和形成纳米液滴:深入了解药物物理化学性质和聚合物选择的作用。
Mol Pharm. 2021 May 3;18(5):2066-2081. doi: 10.1021/acs.molpharmaceut.1c00055. Epub 2021 Mar 30.
8
Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.利托那韦-共聚维酮无定形固体分散体的溶解机制研究:一致释放对于增强性能的重要性。
Mol Pharm. 2019 Mar 4;16(3):1327-1339. doi: 10.1021/acs.molpharmaceut.8b01261. Epub 2019 Feb 5.
9
Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.无定形固体分散体中相分离/结晶和吸水的相互影响。
Mol Pharm. 2018 Feb 5;15(2):669-678. doi: 10.1021/acs.molpharmaceut.7b01076. Epub 2018 Jan 19.
10
Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.利托那韦无定形固体分散体在水合和溶解过程中的相行为。
Pharm Res. 2017 Dec;34(12):2842-2861. doi: 10.1007/s11095-017-2265-5. Epub 2017 Sep 27.

本文引用的文献

1
The Implications of Drug-Polymer Interactions on the Physical Stability of Amorphous Solid Dispersions.药物-聚合物相互作用对无定形固体分散体物理稳定性的影响。
Pharm Res. 2023 Dec;40(12):2963-2981. doi: 10.1007/s11095-023-03547-4. Epub 2023 Jun 30.
2
Investigating and Comparing the Applicability of the R3m Molecular Descriptor and Solubility Parameter Estimation Approaches in Predicting Dispersion Formation Potential of APIs in a Random Co-Polymer Polyvinylpyrrolidone Vinyl Acetate and its Homopolymer.研究并比较R3m分子描述符和溶解度参数估算方法在预测活性药物成分在无规共聚物聚乙烯吡咯烷酮-醋酸乙烯酯及其均聚物中形成分散体潜力方面的适用性。
J Pharm Sci. 2023 Jan;112(1):318-327. doi: 10.1016/j.xphs.2022.11.004. Epub 2022 Nov 14.
3
Considerations in the Development of Physically Stable High Drug Load API- Polymer Amorphous Solid Dispersions in the Glassy State.
在玻璃态下开发物理稳定的高载药量 API-聚合物无定形固体分散体时需要考虑的因素。
J Pharm Sci. 2023 Jan;112(1):8-18. doi: 10.1016/j.xphs.2022.08.007. Epub 2022 Aug 7.
4
Interpreting the Physicochemical Meaning of a Molecular Descriptor Which Is Predictive of Amorphous Solid Dispersion Formation in Polyvinylpyrrolidone Vinyl Acetate.解读对预测聚维酮醋酸乙烯酯无定形固体分散体形成有影响的分子描述符的物理化学意义。
Mol Pharm. 2022 Jan 3;19(1):303-317. doi: 10.1021/acs.molpharmaceut.1c00783. Epub 2021 Dec 21.
5
Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing.热加工创新:热熔挤出和 KinetiSol® 分散技术。
AAPS PharmSciTech. 2020 Nov 8;21(8):312. doi: 10.1208/s12249-020-01854-2.
6
Predicting Density of Amorphous Solid Materials Using Molecular Dynamics Simulation.利用分子动力学模拟预测非晶态固体材料的密度。
AAPS PharmSciTech. 2020 Feb 26;21(3):96. doi: 10.1208/s12249-020-1632-4.
7
Analysis of the Literature and Patents on Solid Dispersions from 1980 to 2015.1980 年至 2015 年固体分散体文献与专利分析。
Molecules. 2018 Jul 12;23(7):1697. doi: 10.3390/molecules23071697.
8
Modeling and Prediction of Drug Dispersability in Polyvinylpyrrolidone-Vinyl Acetate Copolymer Using a Molecular Descriptor.利用分子描述符对聚乙烯吡咯烷酮-醋酸乙烯酯共聚物中药物分散性的建模与预测
J Pharm Sci. 2018 Jan;107(1):334-343. doi: 10.1016/j.xphs.2017.10.003. Epub 2017 Oct 12.
9
The Cambridge Structural Database.剑桥结构数据库。
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2016 Apr;72(Pt 2):171-9. doi: 10.1107/S2052520616003954. Epub 2016 Apr 1.
10
COMPASS II: extended coverage for polymer and drug-like molecule databases.COMPASS II:聚合物和类药物分子数据库的扩展覆盖范围。
J Mol Model. 2016 Feb;22(2):47. doi: 10.1007/s00894-016-2909-0. Epub 2016 Jan 27.